Explore the critical differences between adrenal adenoma and carcinoma. Understand diagnosis, prognosis, and key pathological features in endocrine medicine.
SummaryThis content differentiates between adrenal adenomas and carcinomas based on their size, gross appearance, histological features, capsular integrity, metastatic potential, and genetic markers. It highlights key diagnostic criteria for malignancy and discusses the prognostic implications of each condition. A separate section covers Multiple Endocrine Neoplasia (MEN) syndromes, detailing the genetic basis, characteristic endocrine gland involvement, and other associated features of MEN1, MEN2A, and MEN2B. Mnemonics are provided for remembering the glandular involvement in MEN syndromes, along with crucial points for screening and management. The document also briefly touches upon parathyroid cell types, distinguishing between chief cells and oxyphil cells based on their size, cytoplasm, function, and granule content. Finally, it delves into Renal Tubular Acidosis (RTA), defining the condition and comparing the different types (Type 1, 2, and 4) based on their defects, urine pH, serum electrolytes, causes, complications, and treatments. Key Points- Adrenal Carcinoma Diagnosis : Confirmed by vascular invasion, capsular invasion, or metastasis; cytology alone is insufficient. - MEN1 Mnemonic : 3 Ps - Parathyroid, Pancreas, Pituitary. - MEN2A Mnemonic : 2 Ps - Parathyroid, Phaeochromocytoma, Medullary thyroid carcinoma. - MEN2B Features : Phaeochromocytoma, Medullary thyroid carcinoma, Marfanoid habitus, mucosal neuromas; no parathyroid involvement . - RET Mutation Management : Screening family members and prophylactic thyroidectomy in carriers. - Chief Cells : Predominant functional cells in the parathyroid gland, responsible for PTH synthesis and secretion. - Oxyphil Cells : Larger parathyroid cells with abundant mitochondria, unknown function, increase with age. - RTA Type 4 Hyperkalaemia : The only type of RTA characterized by hyperkalaemia; others present with hypokalaemia. - Diabetic Nephropathy Pathogenesis : Involves hyperglycaemia-induced AGE formation, hyperfiltration, mesangial expansion, and GBM thickening. - Kimmelstiel-Wilson Nodules : Pathognomonic histological finding in nodular glomerulosclerosis of diabetic nephropathy. - Diabetic Nephropathy Arteriolar Hyalinosis : Affects both afferent and efferent arterioles, distinguishing it from hypertensive nephropathy. - Microalbuminuria : The earliest clinical sign of diabetic nephropathy. - ACEi/ARBs in Diabetic Nephropathy : Slow progression by reducing intraglomerular pressure. - Detailed Notes ADRENAL NEOPLASMS — Adenoma vs Carcinoma Feature Adenoma Carcinoma --- --- --- Size Small, 100g Gross Yellow, well-circumscribed, smooth Grey-white, irregular, necrotic Histology Uniform clear cells, thin capsule, no invasion Pleomorphic cells, mitoses, necrosis, vascular invasion Capsule Intact Breached — invasion is diagnostic Metastasis No Yes — only reliable criterion of malignancy alongside invasion CDC73/parafibromin Intact Mutated in ~70% ACTH Suppressed (autonomous cortisol) Suppressed Prognosis Excellent after adrenalectomy Poor — local recurrence in 1/3, distant metastasis in 1/3 Key point: Cytology alone cannot diagnose carcinoma. Only vascular invasion, capsular invasion, or metastasis confirms malignancy. MEN SYNDROMES (Multiple Endocrine Neoplasia) Feature MEN1 MEN2A MEN2B --- --- --- --- Gene MEN1 (chromosome 11q13, tumour suppressor) RET proto-oncogene RET proto-oncogene Parathyroid Hyperplasia/adenoma Hyperplasia No Pancreas Islet cell tumours (gastrinoma, insulinoma) No No Pituitary Adenoma (prolactinoma most common) No No Adrenal No Phaeochromocytoma Phaeochromocytoma Thyroid No Medullary thyroid carcinoma Medullary thyroid carcinoma Other — — Marfanoid habitus, mucosal neuromas Mnemonic: - MEN1 = 3 Ps — Parathyroid + Pancreas + Pituitary - MEN2A = 2 Ps — Parathyroid + Phaeochromocytoma + medullary thyroid - MEN2B = Phaeochromocytoma + medullary thyroid + marfanoid/neuromas (no parathyroid) - Key points: - MEN1 mutation found in 30–35% of sporadic parathyroid adenomas - RET mutation in MEN2 → screen family members → prophylactic thyroidectomy in carriers - Always screen phaeochromocytoma patients for MEN2 - PARATHYROID CELL TYPES Cell Type Size Cytoplasm Function Granules --- --- --- --- --- Chief cells 12–20 μm, predominant Light to dark pink, polygonal PTH synthesis and secretion PTH secretory granules present Oxyphil cells Larger than chief cells Deeply eosinophilic, packed with mitochondria Unknown (transitional/inactive) Sparse/absent secretory granules Key points: - Chief cells predominate — they are the functional cells - Oxyphil cells increase with age — appear after puberty - Stromal fat increases up to age 25 → plateaus at ~30% of gland - Adenomas mostly composed of chief cells — oxyphil adenomas rare - Water-clear cell hyperplasia — glycogen-rich clear cells, seen in some hyperplasia - RENAL TUBULAR ACIDOSIS (RTA) Definition: Defect in renal acid-base handling → normal anion gap metabolic acidosis despite normal or near-normal GFR. Feature Type 1 (Distal) Type 2 (Proximal) Type 4 --- --- --- --- Defect Impaired H⁺ excretion in collecting duct Impaired HCO₃⁻ reabsorption in proximal tubule Hypoaldosteronism → impaired H⁺ and K⁺ excretion Urine pH Always 5.5 (cannot acidify) 5.5 Serum K⁺ ↓ Hypokalaemia ↓ Hypokalaemia ↑ Hyperkalaemia Serum HCO₃⁻ Very low Moderately low Mildly low Causes Sjögren's, SLE, amphotericin B, medullary sponge kidney Fanconi syndrome, multiple myeloma, Wilson's disease Diabetic nephropathy, ACEi/ARBs, Addison's disease Complications Nephrocalcinosis, nephrolithiasis, osteomalacia Rickets/osteomalacia Arrhythmias from hyperkalaemia Treatment Oral bicarbonate (small doses) Large oral bicarbonate + treat cause Fludrocortisone, dietary K⁺ restriction Key distinguishing point: Type 4 is the only RTA with hyperkalaemia — all others have hypokalaemia. Type 4 is the most common RTA in clinical practice (diabetic nephropathy). DIABETIC NEPHROPATHY — Pathogenesis & Morphology Pathogenesis (stepwise): - Chronic hyperglycaemia → glycation of proteins → AGE formation → mesangial expansion - Hyperglycaemia → ↑ intraglomerular pressure (afferent arteriole dilation efferent) → hyperfiltration → glomerular hypertension - Glomerular hypertension → GBM thickening → proteinuria begins (microalbuminuria) - Progressive mesangial expansion → nodular glomerulosclerosis (Kimmelstiel-Wilson nodules) - Diffuse glomerulosclerosis → ↓ GFR → CKD → ESRD - Morphology: - Diffuse glomerulosclerosis — uniform mesangial matrix expansion — most common finding - Nodular glomerulosclerosis (Kimmelstiel-Wilson nodules) — ovoid/spherical nodules of acellular matrix in periphery of glomerulus — pathognomonic of diabetic nephropathy - GBM thickening - Hyaline arteriolosclerosis — affects both afferent AND efferent arterioles (efferent involvement is unique to DM) - Exudative lesions — hyaline caps, capsular drops - Clinical progression: - Stage 1: Hyperfiltration — ↑ GFR, no proteinuria - Stage 2: Silent — GBM thickening, microstructural changes - Stage 3: Microalbuminuria (30–300 mg/day) — earliest clinical sign - Stage 4: Macroalbuminuria ( 300 mg/day) + ↓ GFR + hypertension - Stage 5: ESRD — dialysis or transplant - Key points: - Microalbuminuria = earliest detectable sign of diabetic nephropathy - ACEi/ARBs — slow progression by reducing intraglomerular pressure (dilate efferent arteriole) - Both afferent and efferent arteriolar hyalinosis — unique to DM, distinguishes from hypertensive nephropathy (afferent only) - Practice Questions- A patient presents with a large, grey-white adrenal mass with irregular borders and areas of necrosis on imaging. Histology reveals pleomorphic cells with evidence of vascular invasion. What is the most likely diagnosis? → Adrenal Carcinoma - A patient has a family history of medullary thyroid cancer and phaeochromocytoma. Genetic testing reveals a mutation in the RET proto-oncogene. This patient is at increased risk for which MEN syndrome? → MEN2A o